Dassault Systèmes: 4% Growth in Q2, Operating Margin Climbs to 30%
On July 23, 2026, Dassault Systèmes released its second-quarter results, aligning with its targets, showing a 4% revenue growth at constant exchange rates and a non-IFRS operating margin of 30%. The company confirms its 2026 trajectory, driven by an acceleration in 3DEXPERIENCE and cloud platforms, but faces a significant slowdown in Life Sciences, a segment it plans to revitalize through the acquisition of ArisGlobal.
3DEXPERIENCE Software and Cloud Accelerate, Life Sciences Decline
In the second quarter, software revenue grew by 4% to 1.40 billion euros in IFRS data (also 4% at constant exchange rates). Two driving lines emerge clearly: 3DEXPERIENCE software jumped by 14% and cloud by 14%, representing 43% and 28% of software revenue respectively. This momentum is rooted in increasing adoption among clients who are transforming their operations around AI-powered virtual twins. Concurrently, the ARR (Annual Recurring Revenue) stands at 4.44 billion euros, up 6% from the previous year at constant exchange rates, reflecting the continuous strengthening of the group's recurring business model. However, Life Sciences recorded a 4% decline in software revenue for the quarter, with Medidata down by 3%, even though this branch is expected to be a major growth lever.
Stabilized Operating Margin and Increased Profitability per Share
The non-IFRS operating margin reached 30.0% in the second quarter, up by 0.7 points from the same period in 2025 (29.3%). The non-IFRS operating result amounted to 467 million euros, growing by 7% at constant exchange rates, illustrating targeted productivity gains within the organization. The non-IFRS diluted net earnings per share reached 0.31 euros for the quarter, up by 8% at constant exchange rates. For the semester, the non-IFRS EPS stands at 0.61 euros, stable in reported data but growing by 6% at constant exchange rates. In the first half, operational cash flow rose to 1.24 billion euros, up by 11%, with a solid cash conversion that strengthens the group's ability to fund its strategic investments and acquisitions.
2026 Guidance Confirmed and ArisGlobal Acquisition to Reinvigorate Life Sciences
Dassault Systèmes confirms its non-IFRS targets for the fiscal year 2026, capitalizing on the performance of the first half. The group anticipates a revenue growth of 1% to 3% at constant exchange rates and an operating margin between 32.2% and 32.6% for the full year. The growth in software revenue and service provision is expected between 3% and 5%, reflecting an anticipated acceleration in the second half. The acquisition of ArisGlobal, announced on July 23, 2026, marks a key milestone. The group aims to create a unified AI platform in Life Sciences, linking molecule, patient, and real-world outcomes. Combining Dassault's leadership in scientific modeling and simulation with ArisGlobal's expertise in intelligent safety and compliance, the operation is expected to positively contribute to revenue growth and be accretive to EPS from the first year following closure. Concurrently, the group is enriching its 3DEXPERIENCE platform with new Virtual Companion capabilities, strengthening its positioning in agent-based AI.
